How antidepressants, ketamine and psychedelic drugs may make brains more flexible – new research
The first-line pharmacological treatment for major depressive disorder (MDD) are antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). But a significant proportion of people don’t respond to these drugs. Given that major depression is a global mental health problem that is on the increase, it is important to find novel pharmacological treatments for those […]
Continue Reading